Clinical Trials Browser

Phase 3 × Active not recruiting × Lymphoma, Follicular × Clear all

Lymphoma, Follicular, Recurrence

NCT06097364 2026-02-06

OLYMPIA-2

Phase 3 Active not recruiting

733 enrolled

Lymphoid

Lymphoma, Follicular, Recurrence

NCT04712097 2026-02-04

Celestimo

Phase 3 Active not recruiting

478 enrolled

Lymphoid

Lymphoma, Follicular, Recurrence

NCT04680052 2025-12-22

InMIND

Phase 3 Active not recruiting

654 enrolled 40 charts 3 FDA

Lymphoid

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

NCT02390869 2025-12-02

FIL_RENOIR12

Phase 3 Active not recruiting

128 enrolled

Lymphoid

Lymphoma, Follicular, Recurrence

NCT05371093 2025-10-15

ZUMA-22

Phase 3 Active not recruiting

231 enrolled

Lymphoid

Lymphoma, Follicular

NCT05058404 2025-09-03

Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma

Phase 3 Active not recruiting

605 enrolled

Lymphoid

Lymphoma, Follicular

NCT05409066 2025-07-28

EPCORE FL-1

Phase 3 Active not recruiting

549 enrolled 5 FDA

Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms

NCT04904536 2025-04-10

STRONGER

Phase 3 Active not recruiting

190 enrolled

Lymphoid

COVID-19, Lymphoma, Follicular, Neurologic Manifestations

NCT00877214 2024-08-22

MAINTAIN

Phase 3 Active not recruiting

1,272 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

Clinical Trials

LEDA

OLYMPIA-2

Celestimo

InMIND

FIL_RENOIR12

ZUMA-22

Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma

EPCORE FL-1

STRONGER

MAINTAIN